Medical research

Target found to arrest cancer growth

Adelaide researchers are homing in on a new treatment target for the aggressive blood cancer multiple myeloma.

Medications

Daratumumab cuts risk for progression in multiple myeloma

(HealthDay)—For patients with newly diagnosed multiple myeloma, the addition of daratumumab to lenalidomide and dexamethasone is associated with a reduced risk for disease progression or death, according to a study published ...

page 1 from 23